Julien Cherfils‐Vicini

Author

Inserm ORCID

Also Known As

Cherfils-Vicini, Julien, Christian Jorgensen, Gaël Cristofari, Julien Cherfils-Vicini, Julien Cherfils‐Vicini

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Inserm Institut de Recherche sur le Cancer et le Vieillissement de Nice Centre National de la Recherche Scientifique Sorbonne Université Université Côte d'Azur

About

Julien Cherfils‐Vicini is an author at Inserm specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	1.8K
2	Cell Biology	11	11	1.5K
3	Natural Sciences	1	1	154
4	Allergy	1	1	28
5	Biochemistry	1	1	14

Julien Cherfils‐Vicini

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells Antoine Marçais, Julien Cherfils‐Vicini, Charlotte Viant, Nature Immunology Cancer ImmunosurveillanceCell RegulationMedicineImmunologyCell Death	2014	585
Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma Sophia Platonova, Julien Cherfils‐Vicini, Diane Damotte, Cancer Research	2011	475
Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance Julien Cherfils‐Vicini, Sophia Platonova, Mélanie Gillard, Journal of Clinical Investigation Tlr8 AgonistsCancer ImmunosurveillanceLung InflammationTlr LigandsTumor Growth	2010	228
Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-β activation Alexandra Mousset, Enora Lecorgne, Isabelle Bourget, Cancer Cell InflammationCancer ImmunosurveillanceNeutrophil Extracellular TrapsGranulocyteMedicine	2023	214
TRF2-Mediated Control of Telomere DNA Topology as a Mechanism for Chromosome-End Protection Delphine Benarroch-Popivker, Sabrina Pisano, Aarón Méndez-Bermúdez, Molecular Cell ChromatinGenome InstabilityTelomere Dna TopologyChromosome-end ProtectionNatural Sciences	2016	154
TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells Annamaria Biroccio, Julien Cherfils‐Vicini, Adeline Augereau, Nature Cell Biology Cancer ResearchNatural Killer CellsCancer ImmunosurveillanceMedicineImmunology	2013	124
Genetic and Pharmacological Inactivation of the Purinergic P2RX7 Receptor Dampens Inflammation but Increases Tumor Incidence in a Mouse Model of Colitis-Associated Cancer Paul Hofman, Julien Cherfils‐Vicini, Marie Bazin, Cancer Research Gastrointestinal PharmacologyImmunologyGastroenterologyPathologyCell Death	2015	112
TLR7 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non–Small Cell Lung Cancer Saradiya Chatterjee, Lucile Crozet, Diane Damotte, Cancer Research Poor Clinical OutcomesImmunologyImmune RegulationPathologyImmunotherapeutics	2014	107
The Wilms’ tumour suppressor Wt1 is a major regulator of tumour angiogenesis and progression Kay‐Dietrich Wagner, Julien Cherfils‐Vicini, Naoki Hosen, Nature Communications Tumor BiologyAngiogenesisMedicinePathologyTumour Angiogenesis	2014	89
A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy Laëtitia Douguet, Séréna Janho dit Hreich, Jonathan Benzaquen, Nature Communications	2021	88

Page 1